Avidity Biosciences, Inc. (RNA) Initiated with a Strong Buy at Raymond James

Avidity Biosciences, Inc. (RNA) Initiated with a Strong Buy at Raymond James
Raymond James initiates coverage on Avidity Biosciences, Inc. (NASDAQ:RNA) with a Strong Buy rating and $65 price target.